CVS Health Corporation (CVS)
58.36 USD -2.27 (-3.74%) Volume: 15.89M
CVS Health Corporation’s stock price stands at 58.36 USD, marking a decrease of -3.74% this trading session, with a trading volume of 15.89M. The stock’s performance has seen a significant decline YTD, with a percentage change of -26.09%, reflecting a challenging market for CVS.
Latest developments on CVS Health Corporation
Investors are closely monitoring CVS Health Corporation (CVS) as the stock price experiences fluctuations in the market. Despite daily gains, CVS Health Corp. stock underperformed compared to competitors on both Tuesday and Wednesday. The recent drop in share prices may be attributed to possible sympathy trading with Walgreens Boots Alliance. Interestingly, CVS Health stock found support at a crucial level, indicating a potential turnaround in the near future. In other news, Choctaw Nation is seeking a rehearing in a dispute with CVS regarding arbitration. Stay tuned for more updates on CVS Health Corp’s stock movements.
CVS Health Corporation on Smartkarma
Analysts on Smartkarma, like Baptista Research, are closely monitoring Cvs Health Corp‘s performance. In their report “CVS Health Corporation: Will The Increasing Margin in Medicare Advantage Last? – Major Drivers,” they highlight the company’s Q1 2024 earnings showing a mix of positive and negative impacts. The earnings per share fell short at $1.31 due to utilization pressures in Medicare Advantage, affecting the Health Care Benefits segment. As a result, CVS has adjusted its full-year guidance for adjusted EPS to at least $7.
Another report by Baptista Research, “CVS Health Corporation: Integration Of Acquired Businesses,” delves into the company’s ability to navigate challenges and meet financial commitments. The analysts emphasize the strength of CVS Health’s diversified business model and conduct a fundamental analysis using a Discounted Cash Flow methodology. This analysis aims to evaluate various factors that could influence the company’s stock price in the near future, providing valuable insights for investors on Smartkarma.
A look at CVS Health Corporation Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 5 | |
Dividend | 5 | |
Growth | 3 | |
Resilience | 3 | |
Momentum | 3 | |
OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, CVS Health Corp is looking strong in terms of value and dividend. With top scores in both categories, investors can expect solid returns and consistent payouts from the company. However, the growth, resilience, and momentum scores are slightly lower, indicating some challenges in these areas. Overall, CVS Health Corp remains a solid choice for investors looking for stability and income.
As an integrated pharmacy health care provider, CVS Health Corporation offers a range of services including pharmacy benefit management, retail pharmacy, and disease management programs. With a strong presence across the U.S., the company operates numerous drugstores and retail clinics, providing essential healthcare services to customers. Despite facing some challenges in growth and momentum, CVS Health Corp’s high scores in value and dividend highlight its stability and commitment to delivering returns to shareholders.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars